期刊文献+

β-肌球蛋白重链基因与家族性肥厚型心肌病 被引量:1

下载PDF
导出
摘要 家族性肥厚型心肌病(familial hypertrophic cardiomyopathy,FHCM)是一种常染色体显性遗传病,肥厚型心肌病临床表现存在很大差异,从无症状到黑朦、晕厥、胸痛、心律失常及心力衰竭等不尽相同,很多青年患者往往平时无症状或首发症状就是猝死。目前,分子遗传学研究已经确定了HCM至少存在13个致病基因。其中,MYH7基因是最常见的致病基因。国内外的研究数据均提示MYH7基因是突变发生率最高的HCM致病基因,在中国黄种人FHCM患者中MYH7基因突变发生率为41%。到目前为止已经发现了超过400种突变可以引起HCM,而位于MYH7基因上的就近200种。因此作为13个已知的致病基因之一,该文对MYH7基因和FHCM的关系作一综述。
出处 《国际心血管病杂志》 2010年第6期346-348,360,共4页 International Journal of Cardiovascular Disease
  • 相关文献

参考文献4

二级参考文献46

  • 1谢文丽,刘文玲,胡大一,崔炜,朱天刚,李翠兰,孙艺红,李蕾,李田昌,边红,仝其广.汉族家族性肥厚型心肌病患者的MYH7基因R663H、E924K突变[J].中华医学杂志,2004,84(19):1610-1613. 被引量:4
  • 2Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kind reds with distinct and identical beta-myosin heavy chain gene mutations. Circulation, 1994,89:22-32.
  • 3Havndrup O, Bundgaard H, Andersen PS, et al. The Val606Met mutation in the cardiac beta-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age. Am J Cardiol, 2001,87 : 1315- 1317.
  • 4Watkins H, Rosenzweig A, Hwang DS, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med, 1992, 326 : 1108- 1114.
  • 5Anan R, Greve G,Thierfelder L, et al. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest, 1994,94 : 280- 285.
  • 6Ingles J, Doolan A, Chiu C, et al. Compound and double mutations in patients with hypertrophic cardiomyopathy : implications for genetic testing and counselling. J Med Genet, 2005,42 : e.59.
  • 7Cuda G, Fananapazir L, Epstein ND, et al. The in vitro motility activity of beta-cardiac myosin depends on the nature of the betamyosin heavy chain gene mutation in hypertrophic cardiomyopathy. J Muscle Res Cell Motil, 1997,18:275-283.
  • 8Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol, 2008, 19:104-110.
  • 9Zou Y, Song L, Wang Z, et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. Am J Med, 2004, 116:14-18.
  • 10Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med, 2008, 5:158-168.

共引文献13

同被引文献33

  • 1赵航,舒先红.肥厚型心肌病预后评估的研究进展[J].心血管病学进展,2007,28(1):33-36. 被引量:6
  • 2王俊宏,张寄南.肌钙蛋白Ⅰ突变致肥厚型心肌病的发病机制[J].国际心血管病杂志,2007,34(4):274-276. 被引量:1
  • 3OMAHONY C ,ELLIOTY P M. Prevention of sudden cardiac death in hypertrophic cardiomyopathy [ J ]. Heart ,2014,100 (3) :254-260.
  • 4GERSH B J,MARON B J,BONOW R O,et al. 2011 ACCF/AHA guideline for the diagnosis and~treatment of hypertrophic cardiomyop- athy : a report of the American College of Cardiology Foundation/A- merican Heart Association Task Force on Practice Guidelines [ J ]. Circulation ,2011,124 (24) : e783-e831.
  • 5ELLIOTE P, MCKENNA W J. Hypertrophic cardiomyopathy [ J ]. Lancet ,2004,363 (9424) : 1881-1891.
  • 6PAOLO S, AUTORE C, CLAUDIO R, et al. Scope and risk of sudden death in hypertrophic cardiomyopathy [ J ]. Circulation, 2009, 119 (13) :1703-1710.
  • 7MUNCH J, AYDIN A, SULING A, et al. Orthostatic blood pressure test for risk stratification in patients with hypertrophic cardiomyopathy [J]. PLoS One,2015,10(6) :e0131044.
  • 8KATRITSIS D G, ZAREBA W, CAMM A J, et al. Non-sustained ven- tricular tachycardia [ J ]. J Am Coil Cardiol, 2012,60 ( 20 ) : 1993- 2004.
  • 9ARIS A, ARIEMISIA T, ANGELOS R, et al. Risk factors in hyper- trophic cardiomyopathy [ J ]. Hellenic J of Cardio1,2013,54 (4) :281 - 288.
  • 10BOSTAN C, SINAN U Y, CANBOLAT P, et al. Factors predicting long-term mortality in patients with hypertrophic cardiomyopathy [ J~. Echocardiography ,2014,31 ( 9 ) : 1056-1061.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部